Prevention of malaria in travelers

American Family Physician

Volumn 85, Issue 10, 2012, Pages 973-977

  Johnson, Brett A ^a   Kalra, Monica G ^a  

^a METHODIST HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATOVAQUONE PLUS PROGUANIL; CHLOROQUINE; DIETHYLTOLUAMIDE; DOXYCYCLINE; ICARIDIN; MEFLOQUINE; PRIMAQUINE;

ABDOMINAL PAIN; ALLERGIC REACTION; ANOPHELES; ARTHRALGIA; ARTICLE; BED NET; BLURRED VISION; CHEMOPROPHYLAXIS; CHILL; DERMATITIS; DIARRHEA; FEVER; HALLUCINATION; HEADACHE; HEARING LOSS; HEMOLYSIS; HUMAN; INSECT BITE; INSOMNIA; MALARIA; NAUSEA; NEUROTOXICITY; PARANOIA; PARASITE TRANSMISSION; PHOTOSENSITIVITY; PROPHYLAXIS; RISK ASSESSMENT; SEIZURE; SIDE EFFECT; TINNITUS; TRAVEL; VAGINA CANDIDIASIS; VOMITING;

EID: 84861589146     PISSN: 0002838X     EISSN: 15320650     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Centers for Disease Control and Prevention. Malaria-malaria facts. http://www.cdc.gov/malaria/about/facts.html. Accessed December 12, 2011.
2. Mali S, Tan KR, Arguin PM; Division of Parasitic Diseases and Malaria, Center for Global Health; Centers for Disease Control and Prevention. Malaria surveillance-United States, 2009. MMWR Surveill Summ. 2011;60(3):1-15.
3. Pascual M, Ahumada JA, Chaves LF, Rodó X, Bouma M. Malaria resurgence in the East African highlands: temperature trends revisited. Proc Natl Acad Sci USA. 2006;103(15):5829-5834.
4. Freedman DO. Clinical practice. Malaria prevention in short-term travelers. N Engl J Med. 2008;359(6):603-612.
5. Centers for Disease Control and Prevention. Malaria-disease. http:// www.cdc.gov/malaria/about/disease.html. Accessed August 15, 2010.
6. World Health Organization. World Malaria Report: 2010. http://www. who.int/malaria/world_malaria_report_2010/en/index.html. Accessed December 12, 2011.
7. Muhe L, Oljira B, Degefu H, Enquesellassie F, Weber MW. Clinical algorithm for malaria during low and high transmission seasons. Arch Dis Child. 1999;81(3):216-220.
8. Briët OJ, Vounatsou P, Gunawardena DM, Galappaththy GN, Amerasinghe PH. Temporal correlation between malaria and rainfall in Sri Lanka. Malar J. 2008;7:77.
9. Hill N, Lenglet A, Arnéz AM, Carneiro I. Plant based insect repellent and insecticide treated bed nets to protect against malaria in areas of early evening biting vectors: double blind randomised placebo controlled clinical trial in the Bolivian Amazon. BMJ. 2007;335(7628):1023.
10. Centers for Disease Control and Prevention. Malaria-malaria and travelers. http://www.cdc.gov/malaria/travelers/index.html. Accessed July 8, 2011.
11. Fradin MS, Day JF. Comparative efficacy of insect repellents against mosquito bites. N Engl J Med. 2002;347(1):13-18.
12. American Academy of Pediatrics. Follow safety precautions when using DEET on children. AAP News. 2003;22(5):200399. http://aapnews.aap publications.org/cgi/content/full/e200399v1 (subscription required). Accessed July 1, 2011.
13. Frances SP, Waterson DG, Beebe NW, Cooper RD. Field evaluation of repellent formulations containing deet and picaridin against mosquitoes in Northern Territory, Australia. J Med Entomol. 2004;41(3):414-417.
14. Moore SJ, Darling ST, Sihuincha M, Padilla N, Devine GJ. A low-cost repellent for malaria vectors in the Americas: results of two field trials in Guatemala and Peru. Malar J. 2007;6:101.
15. U.S. Environmental Protection Agency. Pesticides: regulating pesticides-p-Menthane-3,8-diol (011550) fact sheet. http://www.epa.gov/ oppbppd1/biopesticides/ingredients/factsheets/factsheet_011550. htm. Accessed July 1, 2011.
16. Pennetier C, Corbel V, Boko P, et al. Synergy between repellents and non-pyrethroid insecticides strongly extends the efficacy of treated nets against Anopheles gambiae. Malar J. 2007;6:38.
17. Kimani EW, Vulule JM, Kuria IW, Mugisha F. Use of insecticide-treated clothes for personal protection against malaria: a community trial. Malar J. 2006;5:63.
18. Centers for Disease Control and Prevention. Malaria-choosing a drug to prevent malaria. http://www.cdc.gov/malaria/travelers/drugs.html. Accessed August 15, 2010.
19. Gutman J, Green M, Durand S, et al. Mefloquine pharmacokinetics and mefloquine-artesunate effectiveness in Peruvian patients with uncomplicated Plasmodium falciparum malaria. Malar J. 2009;8:58.
20. Nevin RL, Pietrusiak PP, Caci JB. Prevalence of contraindications to mefloquine use among USA military personnel deployed to Afghanistan. Malar J. 2008;7:30.
21. Hill DR, Baird JK, Parise ME, Lewis LS, Ryan ET, Magill AJ. Primaquine: report from CDC expert meeting on malaria chemoprophylaxis I. Am J Trop Med Hyg. 2006;75(3):402-415.
22. Baird JK, Hoffman SL. Primaquine therapy for malaria. Clin Infect Dis. 2004;39(9):1336-1345.
23. Centers for Disease Control and Prevention. Travelers' health-infectious diseases related to travel: malaria. http://wwwnc.cdc.gov/travel/ yellowbook/2012/chapter-3-infectious-diseases-related-to-travel / malaria.htm. Acessed July 8, 2011.
24. Abdulla S, Oberholzer R, Juma O, et al. Safety and immunogenicity of RTS,S/AS02D malaria vaccine in infants. N Engl J Med. 2008;359(24): 2533-2544.